openPR Logo
Press release

Co-Chairs invitation to SMi’s 9th Annual Pharmaceutical Microbiology Conference

10-18-2019 11:57 AM CET | Health & Medicine

Press release from: SMi Group

SMi Reports: James Drinkwater and Olivier Chancel release an invitation chair letter for the Pharmaceutical Microbiology Conference, in London.

SMi Group is delighted to present the return of Pharmaceutical Microbiology Conference for its 9th year, commencing on 20th and 21st January 2020, in London. The event focuses on topics regarding technology developments that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.

The conference will be co-chaired by James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society and Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Boehringer Ingelheim, in which they have released an invitation letter for all interested parties.

Excerpt of the Co-Chair invitation letter:

“As the co-chairs of SMi’s 2020 Pharmaceutical Microbiology UK Conference and on behalf of SMi Group, we are delighted to cordially invite you to our conference (20 & 21 January 2020 and workshop day (22 January 2020), at the Copthorne Tara Hotel, London, UK.

At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: environmental monitoring and contamination control strategies, process automation, and discussing updates to meet regulatory requirements.

This year’s conference will explore guidance and regulation including the regulatory expectations on bio-contamination control and insights into the impact of Annex 1 revisions on sterile pharmaceutical product manufacturing. Furthermore, there will be an exploration into microbial detection as well as environmental monitoring and contamination controls.”

For those interested in attending, there is an early bird offer of £200 savings for bookings made by 31st October. Register at www.pharma-microbiology.com/PR2

This year will also include a new addition to the agenda, where a post-conference Interactive Workshop Day will take place on 22nd January.

The pharmaceutical microbiology workshop day will discuss how to develop risk-based approaches to cleaning and disinfection, designing an environmental monitoring programme and rapid micro methods, endotoxin testing and LER through three insightful interactive workshops.

8.30 – 11.40 - Workshop A: Jim Polarine, Senior Technical Service Manager, STERIS Corporation on ‘How to Develop a Risk based Approach to Cleaning and Disinfection’

12.40 - 15.40 - Workshop B: Ian Symonds, Director/Pharmaceutical Consultant, SDA Pharma on ‘Designing an Environmental Monitoring Programme’

15.40 - 18.40 - Workshop C: Felix Alejandro Montero Julian, Scientific Director, bioMérieux and Stefane Schweicher, Business Development Manager Endotoxin NEC, bioMérieux on ‘Rapid Micro Methods, Endotoxin Testing and lER’

The full agenda, chair letter and speaker line-up are available online at www.pharma-microbiology.com/PR2

Proudly sponsored by:
Associates of Cape Cod, bioMérieux, COPAN, METTLER TOLEDO, Microbiologics, Microgenetics, Reading Scientific Services Limited, Veltek Associates

Contact Information:
For sponsorship enquiries contact Alia Malick, Director on +44 (0)20 7827 6164 or email amalick@smi-online.co.uk

For media enquiries, call Simi Sapal on +44 (0) 207 827 6162 or email ssapal@smi-online.co.uk

Pharmaceutical Microbiology UK
Conference: 20 – 21 January 2020
Workshop Day: 22 January 2020
Copthrone Tara Hotel, London, UK
www.pharma-microbiology.com/PR2
#SMiPharmaMicroUK

45 Curlew Street
Ground Floor
London
SE1 2ND

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Co-Chairs invitation to SMi’s 9th Annual Pharmaceutical Microbiology Conference here

News-ID: 1852333 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the